These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The value of tocainide in the treatment of tinnitus. A double-blind controlled study. Hulshof JH, Vermeij P. Arch Otorhinolaryngol; 1985 Jul 10; 241(3):279-83. PubMed ID: 3161487 [Abstract] [Full Text] [Related]
11. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. Mahapatra RK, Mahapatra D. Angiology; 1986 Apr 10; 37(4):285-93. PubMed ID: 2424347 [Abstract] [Full Text] [Related]
13. Possible hepatoxicity of tocainide. Farquhar DL, Davidson NM. Scott Med J; 1984 Oct 10; 29(4):238. PubMed ID: 6442465 [Abstract] [Full Text] [Related]
14. Tocainide in the cardiac ICU. Benning CA, Burke PA. Crit Care Nurse; 1989 Feb 10; 9(2):45-53. PubMed ID: 2510974 [No Abstract] [Full Text] [Related]
15. Adverse cutaneous drug reactions in a single quaternary referral hospital. Botelho LF, Porro AM, Enokihara MM, Tomimori J. Int J Dermatol; 2016 Apr 10; 55(4):e198-203. PubMed ID: 26710962 [Abstract] [Full Text] [Related]
16. Tocainide-induced granulomatous hepatitis. Tucker LE. JAMA; 1986 Jun 27; 255(24):3362. PubMed ID: 3086580 [No Abstract] [Full Text] [Related]